Publications
Legacy
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
What the Camzyos approval means for patients with obstructive HCM
2
BLA submitted to FDA for Viaskin peanut patch in children aged 4 to 7 years with peanut allergy
3
FDA approves Camzyos for pediatric patients with symptomatic obstructive hypertrophic cardiomyopathy
4
Upadacitinib sustains repigmentation in non-segmental vitiligo through 76 weeks
5